ALK Inhibitors in the Treatment of ALK Positive NSCLC

Background: ALK inhibitors have shown positive advance in the treatment of ALK+ NSCLC. They have achieved better results in prolonging the progression free survival and improving quality of life in comparison to chemotherapy. We have assembled the evidence related to the efficacy and safety of these...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Oncol
Main Authors: Khan, Muhammad, Lin, Jie, Liao, Guixiang, Tian, Yunhong, Liang, Yingying, Li, Rong, Liu, Mengzhong, Yuan, Yawei
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2019
主題:
Oncology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6333640/
https://ncbi.nlm.nih.gov/pubmed/30687633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00557
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍